site stats

Immunic market cap

Witryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … Witryna7 kwi 2024 · MoneyLion Inc.’s market cap currently stands at around $133.26 million, with investors looking forward to this quarter’s earnings report slated for May 10, 2024 – May 15, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.06, which has seen fiscal year 2024 EPS growth forecast to increase to -$0.21 and about …

Immunic, Inc. Announces Closing of $103.5 Million Public Offering ...

WitrynaImmunic (IMUX) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Enterprise Value/Market Cap N/A. Enterprise Value/Revenue N/A. Enterprise Value/Gross Profit-10.00T> Enterprise Value/Ebitda 0.53. Forecast. 1Y Price Target. … Witryna12 kwi 2024 · 5 analysts have issued 12 month price targets for Immunic's shares. Their IMUX share price forecasts range from $5.00 to $39.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 1,554.1% from the stock's current price. sharing bluetooth on ipad https://josephpurdie.com

Cryptocurrency Prices, Charts And Market Capitalizations CoinMarketCap

Witryna10 sie 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications Group Melody Carey +1-917-322-2571 [email protected] SOURCE ... Witryna2 dni temu · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … Witryna20 mar 2024 · What is Immunic's Market Cap? ( NASDAQ: IMUX) Immunic 's market cap is $74.15M, as of Mar 22, 2024. Market cap (market capitalization) is the total … poppy ghost game

GSK growth outlook being overlooked due to Zantac concerns

Category:Immunic Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

Tags:Immunic market cap

Immunic market cap

Immunic (IMUX) Stock Price & Analysis - TipRanks

WitrynaImmunic, cost to borrow history and number of IMUX shares available to borrow. companies: 7,324 total market cap: $87.045 T. Global ranking; Ranking by countries. … WitrynaMarket Cap. $59.1M. Currency in USD. Quote data delayed by at least 15 minutes. Immunic, Inc. 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected]. Immunic AG. Lochhamer Schlag 21 82166 Gräfelfing Germany Phone: +49 89 2080 477 00 Email: [email protected].

Immunic market cap

Did you know?

WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net Witryna26 mar 2024 · 6.5%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: IMUX is more volatile than 75% of US …

Witryna10 kwi 2024 · A high-level overview of Immunic, Inc. (IMUX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WitrynaImmunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule …

Witryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology ... WitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ...

Witryna6 kwi 2024 · Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC).. The company on Wednesday said data from the maintenance phase of …

WitrynaInvista em Immunic, NASDAQ: IMUX Ação - Veja o preçário IMUX em tempo real. Comissões grátis online em investimentos em Immunic: compra ou venda Immunic Ação sem custos de comissão com a Trading 212. Tal como com qualquer investimento, o seu capital está em risco. Os investimentos podem cair e subir e poderá obter um … sharing bookWitryna15 kwi 2024 · Aegis Capital bewertet die Aktie positiv mit einem Kauf-Rating. 22 März 2024 ... Veganer Markt. Rating nach Charttechnik. Überverkaufte Aktien. Überkaufte Aktien. Nahe am Widerstand. ... News auf Englisch zu IMMUNIC, INC. 13.03. Immunic, Inc. : Regulation FD Disclosure (form 8-K) AQ. 23.02. Immunic : Q4 2024 News … sharing bluetoothWitryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani … sharing bluetooth connection headphonesWitryna7 sty 2024 · Vital Therapies and Immunic will host a conference call at 8:00 a.m. ET on January 7, to discuss the proposed transaction. The conference call may be accessed by dialing +1 (855) 765-5682 for U.S ... poppy gives birth trollsWitryna12 kwi 2024 · SVB Securities Reaffirms Their Hold Rating on Immunic (IMUX) markets.businessinsider.com - November 21 at 10:04 AM: Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript seekingalpha.com - November 6 at 5:38 AM: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update … poppy glass hanging bird feederWitryna6 kwi 2024 · Immunic, Inc. meldet Ergebnis für das am 31. Dezember 2024 beendete Geschäftsjahr. 22.02. Immunic, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium mit einer Pipeline von selektiven oralen Immunologie-Therapien, die sich auf die Behandlung von chronischen Entzündungs- und … poppy gift shop ocean springs msWitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent … poppy gilbert actress wiki